Anti-SCRN1 antibody (ab105355)
Key features and details
- Rabbit polyclonal to SCRN1
- Suitable for: ICC/IF, WB, IHC-P
- Reacts with: Human
- Isotype: IgG
Overview
-
Product name
Anti-SCRN1 antibody -
Description
Rabbit polyclonal to SCRN1 -
Host species
Rabbit -
Tested applications
Suitable for: ICC/IF, WB, IHC-Pmore details -
Species reactivity
Reacts with: Human -
Immunogen
20 amino acid synthetic peptide to a region within the C-terminus of Human SCRN1 (NP_001138985).
-
Positive control
- Human kidney tissue
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at 4°C (stable for up to 12 months). Store at -20°C or -80°C. -
Storage buffer
pH: 7.2
Preservative: 0.02% Sodium azide
Constituent: PBS -
Concentration information loading... -
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
Western blot - Anti-SCRN1 antibody (ab105355)All lanes : Anti-SCRN1 antibody (ab105355) at 1 µg/ml
Lane 1 : Human kidney tissue lysate
Lane 2 : Human kidney tissue lysate with blocking peptide
Lysates/proteins at 15 µg per lane.
Predicted band size: 46 kDa
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SCRN1 antibody (ab105355)ab105355, at 5ug/ml, staining SCRN1 in Human kidney tissue by immunohistochemistry. -
Immunocytochemistry/ Immunofluorescence - Anti-SCRN1 antibody (ab105355)Immunofluorescence of SCRN1 in Human Kidney cells using ab105355 at 20 ug/ml.
